Organ preservation in rectal cancer: the GRECCAR12 randomized phase 3 trial (NCT02514278)

被引:0
作者
Vendrely, Veronique [1 ]
Fernandez, Benjamin [2 ]
Giraud, Nicolas [1 ]
Rouanet, Philippe [3 ]
Tuech, Jean-Jacques [4 ]
Cotte, Eddy [5 ]
Lefevre, Jeremie [6 ]
Dubois, Anne [7 ]
Germain, Adeline [8 ]
Camerlo, Antoine [6 ]
Lelong, Bernard [9 ]
Valverde, Alain [10 ]
Lakkis, Zaher [11 ]
Rivoire, Michel [12 ]
Desfourneaux, Veronique [13 ]
Conroy, Thierry [14 ]
Asselineau, Julien [15 ]
Denost, Quentin [16 ]
Frison, Eric [15 ]
Rullier, Eric [2 ]
机构
[1] CHU Bordeaux, Radiotherapy, Bordeaux, France
[2] CHU Bordeaux, Surg, Bordeaux, France
[3] Inst Canc Montpellier, Surg, Montpellier, France
[4] CHU Rouen, Surg, Rouen, France
[5] CHU Lyon, Surg, Lyon, France
[6] APHP, Surg, Paris, France
[7] CHU Clermont Ferrand, Surg, Lermont Ferrand, France
[8] CHU Nancy, Surg, Nancy, France
[9] IPC, Surg, Marseille, France
[10] La Croix St Simon, Surg, Paris, France
[11] CHU Besancon, Surg, Esancon, France
[12] Ctr Leon Berard, Surg, Lyon, France
[13] CHU Rennes, Surg, Rennes, France
[14] Inst Cancerol Loraine, Oncol, Nancy, France
[15] CHU Bordeaux, USMR, Bordeaux, France
[16] Bordeaux Colorectal Inst, Surg, Bordeaux, France
关键词
Organ preservation; Rectal cancer; Radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1929
引用
收藏
页码:S1533 / S1534
页数:2
相关论文
共 50 条
[31]   Is preoperative immunotherapy promising for patients with proficient mismatch repair or microsatellite stable locally advanced rectal cancer? - a commentary on TORCH randomized phase 2 trial [J].
Tsukada, Yuichiro ;
Ito, Masaaki .
CHINESE CLINICAL ONCOLOGY, 2024, 14 (02)
[32]   Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial [J].
Simon S. M. Ng ;
Janet F. Y. Lee ;
Raymond Y. C. Yiu ;
Jimmy C. M. Li ;
Sophie S. F. Hon ;
Tony W. C. Mak ;
Dennis K. Y. Ngo ;
Wing Wa Leung ;
Ka Lau Leung .
Surgical Endoscopy, 2014, 28 :297-306
[33]   Randomized phase III trial comparing surgery alone to UFT plus PSK for stage II rectal cancer (JFMC38 trial) [J].
Okuno, Kiyotaka ;
Aoyama, Toru ;
Oba, Koji ;
Yokoyama, Noboru ;
Matsuhashi, Nobuhisa ;
Kunieda, Katsuyuki ;
Nishimura, Yoji ;
Akamatsu, Hiroki ;
Kobatake, Takaya ;
Morita, Satoshi ;
Yoshikawa, Takaki ;
Sakamoto, Junichi ;
Saji, Shigetoyo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) :65-71
[34]   Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial [J].
Ng, Simon S. M. ;
Lee, Janet F. Y. ;
Yiu, Raymond Y. C. ;
Li, Jimmy C. M. ;
Hon, Sophie S. F. ;
Mak, Tony W. C. ;
Ngo, Dennis K. Y. ;
Leung, Wing Wa ;
Leung, Ka Lau .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014, 28 (01) :297-306
[35]   Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, noninferiority, phase 3 trial [J].
Sandra-Petrescu, Flavius ;
Herrle, Florian ;
Burkholder, Iris ;
Kienle, Peter ;
Hofheinz, Ralf-Dieter .
BMC CANCER, 2018, 18
[36]   mFOLFOX6 versus mFOLFOX6 D aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) [J].
Hofheinz, R. -D. ;
Herrle, F. ;
Dechow, T. ;
von Weikersthal, L. F. ;
Welslau, M. ;
Lettmaier, S. ;
Burkart, C. ;
Kubicka, S. ;
Kochen, L. ;
Merx, K. ;
Krause, K. ;
Ebert, M. ;
Roedel, C. ;
Fokas, E. ;
Ghadimi, M. ;
Reissfelder, C. ;
Gaiser, T. .
ESMO OPEN, 2024, 9 (09)
[37]   Organ preservation with primary simultaneous chemoradiation in advanced laryngeal and hypopharyngeal cancer.: Experience of a multi-centre phase II trial [J].
Dietz, A ;
Nollert, J ;
Eckel, H ;
Volling, P ;
Schröder, M ;
Staar, S ;
Conradt, C ;
Helmke, B ;
Dollner, R ;
Müller, RR ;
Wannenmacher, M ;
Weidauer, H ;
Rudat, V .
HNO, 2002, 50 (02) :146-154
[38]   Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial [J].
Feng, Yan-Ru ;
Zhu, Yuan ;
Liu, Lu-Ying ;
Wang, Wei-Hu ;
Wang, Shu-Lian ;
Song, Yong-Wen ;
Wang, Xin ;
Tang, Yuan ;
Liu, Yue-Ping ;
Ren, Hua ;
Fang, Hui ;
Zhang, Shi-Ping ;
Liu, Xin-Fan ;
Yu, Zi-Hao ;
Li, Ye-Xiong ;
Jin, Jing .
ONCOTARGET, 2016, 7 (18) :25576-25584
[39]   Short-term radiotherapy plus chemotherapy for locally advanced rectal cancer: 5-year outcomes of the phase III clinical trial (NCT02533271) [J].
Tang, Yuan ;
Zhou, Haitao ;
Xu, Tongzhen ;
Li, Ning ;
Cai, Yong ;
Li, Yong-Heng ;
Zhu, Yuan ;
He, Ming-Yuan ;
Wang, Xin ;
Liu, Ke ;
Zhang, Hong-Yan ;
Wang, Jun ;
Zhao, Ting ;
Yang, Jia-Lin ;
Zhang, Kuan ;
Wang, Wen-Ling ;
Wang, Shulian ;
Zhang, Hai-Zeng ;
Wang, Xi-Shan ;
Hu, Chen ;
Wei, Li-Chun ;
Liu, Shi-Xin ;
Gao, Yuan-Hong ;
Li, Ye-Xiong ;
Jin, Jing .
RADIOTHERAPY AND ONCOLOGY, 2025, 206 :S1198-S1201
[40]   Effects of Exercise on Motivational Outcomes in Rectal Cancer Patients During and After Neoadjuvant Chemoradiation: A Phase II Randomized Controlled Trial [J].
Arthuso, Fernanda Z. ;
Morielli, Andria R. ;
Usmani, Nawaid ;
Joseph, Kurian ;
Nijjar, Tirath ;
Tankel, Keith ;
Fairchild, Alysa ;
Severin, Diane ;
Boule, Normand G. ;
Courneya, Kerry S. .
SEMINARS IN ONCOLOGY NURSING, 2023, 39 (04)